Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
Mirella Alpa, Dario Roccatello Centro di Ricerche di Immunopatologia e Documentazione su Malattie Rare (CMID), Struttura Complessa Direzione Universitaria di Immunologia Clinica, Università di Torino e Ospedale G Bosco, Torino, ItalyAbstract: Familial Mediterranean fever is an autosomal r...
Main Authors: | Alpa M, Roccatello D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/canakinumab-as-rescue-therapy-in-familial-mediterranean-fever-refracto-peer-reviewed-article-DDDT |
Similar Items
-
Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
by: Afig Berdeli, et al.
Published: (2019-04-01) -
Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
by: Burcu Bozkaya Yücel, et al.
Published: (2021-09-01) -
Two Sisters with Colchicine-Resistant form of Familial Mediterranean Fever on the Canakinumab Therapy: Clinical Case
by: Elena A. Ligostaeva, et al.
Published: (2020-01-01) -
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
by: Kacar M, et al.
Published: (2020-03-01) -
Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
by: Ali Şahin, et al.
Published: (2020-01-01)